Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 26.02% | 39.80% | 31.69% | 12.93% | 1.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.02% | 39.80% | 31.69% | 12.93% | 1.19% |
| Cost of Revenue | 4.31% | 5.48% | 1.82% | 2.38% | 10.75% |
| Gross Profit | 150.48% | 2,104.01% | 7,176.89% | 83.40% | -32.30% |
| SG&A Expenses | 37.00% | 27.84% | 58.66% | 80.33% | 55.46% |
| Depreciation & Amortization | 13.56% | 15.11% | 20.75% | 33.96% | 38.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.88% | 8.78% | 8.46% | 11.20% | 16.37% |
| Operating Income | 347.46% | 140.86% | 111.53% | 71.79% | -154.94% |
| Income Before Tax | -10.91% | 92.98% | 90.98% | 88.44% | 93.30% |
| Income Tax Expenses | 1,189.41% | 75.70% | -131.38% | -138.71% | -102.36% |
| Earnings from Continuing Operations | -22.90% | 93.31% | 92.02% | 89.97% | 93.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -242.18% | -188.36% | -130.18% | -129.69% | -120.31% |
| Net Income | -42.23% | 91.30% | 90.92% | 89.22% | 92.70% |
| EBIT | 347.46% | 140.86% | 111.53% | 71.79% | -154.94% |
| EBITDA | 757.25% | 176.65% | 144.96% | 5.88% | -117.50% |
| EPS Basic | -50.40% | 91.12% | 90.74% | 88.96% | 93.13% |
| Normalized Basic EPS | 77.73% | 77.54% | 38.31% | -1,804.42% | -190.36% |
| EPS Diluted | -50.10% | 90.76% | 90.39% | 88.61% | 92.88% |
| Normalized Diluted EPS | 77.73% | 77.54% | 38.31% | -1,804.42% | -190.36% |
| Average Basic Shares Outstanding | 5.91% | 2.80% | -0.12% | -0.82% | 9.21% |
| Average Diluted Shares Outstanding | 5.91% | 2.80% | -0.12% | -0.82% | 9.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.87% | -1.06% | -0.09% | 0.48% | 0.52% |
